The September issue of Transplantation Direct contains articles in kidney, liver and pancreas transplantation, as well as a methodological report. In kidney transplantation we have articles dealing with: quality of care, bilateral renal parenchymal urine leak after pediatric en bloc transplantation, MSC effects on transfusion-associated sensitization (involvement of transition and regulatory B cells), donor-derived cell-free DNA identification of antibody-mediated rejection, improvement of graft function using antithrombin perfluorocarbon nanoparticles, and long-term results from an efficacy and safety trial using Tofacitinib-based immunosuppression. In liver transplantation, we have an article on the identification and validation of predictive risk factors and models. Related to post-pancreas transplant graft function/survival, there is a report on the impact of deceased donor cardiac arrest time. Methodologically, we have a posttransplant immune monitoring report on anti-HLA donor-specific IgG subclass and C1q-binding evolution. We hope that you find this issue of special interest!
The CTRMS is hosting the 2018 CTRMS Special Workshop on Enabling Technologies. This inaugural special workshop will take place on October 12-14, 2018 at the JW Marriott Starr Pass Resort and Spa in Tucson, Arizona.
At this two-day workshop, key opinion leaders and experts in the fields of bio-imaging, cell targeting, oxygenation, and viability and potency assays (especially for encapsulated cells), will come together to present and discuss cutting-edge research and developments in these key areas and to address remaining critical gaps in encapsulated cell therapies and tissue engineering. Register today to save your spot at this exciting Special Workshop on Enabling Technologies.
We look forward to seeing you there! Please follow this link to our registration page and make sure you renew or join the society to receive the discounted rate. https://www.ctrms.ca/cgi/page.cgi/26/register.html
Robert A. Fisher, M.D., F.A.C.S.
President Cell Transplant and Regenerative Medicine Society
Submitted by Dr Joel Thomas Adler, Editorial Fellow, Transplantation.
Trends in Early Hospital Readmission After Kidney Transplantation, 2002 to 2014: A Population-Based Multicenter Cohort Study
Naylor KL, Knoll GA, Allen B, et al.
Early hospital readmission is considered both a marker of increased morbidity, mortality, and healthcare costs, as well as a quality metric. Using longitudinal, population-based databases in Canada, Naylor et al studied if early hospital readmission incidence has increased concomitant with worsening severity of illness. Defined as readmission within the first 30 days of discharge, the authors found that the cumulative incidence did not increase despite an increasingly ill transplant population. However, approximately 20% did have an early hospital readmission; this serves as a target for continued study and improvement.
August 31 - From October, kidney transplant patients whose family members are incompatible donors can join a scheme that will speed up the time taken to get a new organ. The paired organ donation arrangement, made legal after Hong Kong passed an amendment to its Human Organ Transplant Ordinance last month, allows a donor-patient pair who may not be a match for each other to donate organs to another donor-patient pair and vice versa, so that patients on both sides get the transplants they need.
September 6 - Subset of cells appear to trigger rejection of skin grafts; pre-treating organs could have positive implications for face transplants
August 28 - New research published in The American Journal of Bioethics highlights the ethics of the use of deceased vs living donors in uterus transplantation.
August 24 - The implementation of a kidney allocation system improved equity in access to kidney transplants; however, there were geographic disparities, according to results recently published.
August 27 - Stem cells transformed into 3D human liver tissue by scientists from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh show promising support of liver function when implanted into mice with a liver disease.
Continuing our strong partnership with the International Liver Transplantation Society (ILTS), The Liver Transplant Symposium 2018, organised by the National University Centre for Organ Transplantation (NUCOT), will be held from 19 – 21 October 2018 in Singapore.
The International Pediatric Transplant Association is proud to feature a special section activity: the 2018 Symposium in Organ Transplantation in Children: An educational forum for physicians, surgeons, and allied health professionals.
The focus of this symposium is aimed at clinical and research fellows in pediatric solid organ transplantation, as well as residents, and other allied health professional or non-physician trainees who are planning a career in pediatric transplantation.
On behalf of The Transplantation Society of Taiwan, we would like to extend our warmest invitation to you to join Transplantation Sciences Symposium (TSS) Asian Regional Meeting 2018, which is scheduled to take place at Taipei Marriott Hotel, Taipei, Taiwan from November 23rd to 25th, 2018.
The meeting includes Plenary Lectures (two from TTS Members) Shane Grey and Stefan Tullius, Satellite Symposia, Parallel Presentations and Exhibits. Experts from different domains will be invited to share their expertise and experience in transplantation field. This will be a fabulous chance to exchange the ideas, contribute the most newly developed knowledge, one-of-a-kind cultural and educational experience.
The Transplantation Society
505 Boulevard René-Lévesque Ouest
Montréal, QC, H2Z 1Y7